Compare Cassava Sciences Inc (FLNA) vs Liberty Global Ltd Class C (LBTYK) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

LBTYK trades at $10.49, up 1.16% with mixed technical signals showing bearish moving averages but oversold RSI. The company reported a significant net loss of -$7.14B in 2025 despite $4.88B revenue, though Q1 2026 showed improvement with a positive EPS beat. Analyst sentiment remains strongly bullish with 69% buy ratings, driven by the planned 2027 Ziggo Group spin-off as a key catalyst.

The stock presents a high-risk opportunity with potential upside from sum-of-the-parts valuation and spin-off catalysts, but faces substantial execution risks given persistent losses and competitive telecom pressures. Current valuation metrics (P/S 0.72, P/B 0.37) suggest deep discount to intrinsic value if restructuring succeeds.